Prestige Wealth Management Group LLC Novavax Inc Transaction History
Prestige Wealth Management Group LLC
- $460 Million
- Q3 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Novavax Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 29 shares of NVAX stock, worth $233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 29
-0.0%
Holding current value
$233
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NVAX
# of Institutions
292Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$124 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$95.2 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$78.9 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$61.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$47.7 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $629M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...